KAWAS LEEN

Insider profile

Performance

Overall performance
1.5

Performance over holding periods
1.5
30 days 90 days 120 days
Average return 30% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
KAWAS LEEN's trades of Eiger BioPharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-11-02 2023-10-31 B Purchase
57,459 +17.0%
74.72
US$2,917,720
57,459 +17.0% 74.72 US$2,917,720
2023-11-02 2023-10-31 B Purchase
46,553 +21.8%
263.39
US$773,636
46,553 +21.8% 263.39 US$773,636